Publications

Export 2633 results:
Sort by: Author [ Title  (Asc)] Type Year
A [B] C D E F G H I J K L M N O P Q R S T U V W X Y Z   [Show ALL]
B
Abdelraouf, O. R., A. A. Abdel-Aziem, N. S. Nassif, and A. G. Matar, "Backward walking effects on activation pattern of leg muscles in young females with patellofemoral pain syndrome", International Journal of Therapy and Rehabilitation , 2019.
Abdelraouf, O. R., A. A. Abdel-aziem, A. A. Ahmed, N. S. Nassif, and A. G. matar, Backward walking effects on activation pattern of leg muscles in young females with patellofemoral pain syndrome, , 2019. backward_walking._2019.pdf
Abdelraouf, O. R., A. A. Abdel-aziem, A. A. Ahmed, N. S. Nassif, and A. G. matar, "Backward walking effects on activation pattern of leg muscles in young females with patellofemoral pain syndrome", International Journal of Therapy and Rehabilitation, vol. 26, issue 1, pp. 1-9, 2019. 1st_page.pdf
Abdelraouf, O. R., A. A. Abdel-aziem, A. A. Ahmed, N. S. Nassif, and A. G. matar, "Backward walking effects on activation pattern of leg muscles in young females with patellofemoral pain syndrome", International Journal of Therapy and Rehabilitation, vol. 26, issue 1, pp. 1-9, 2019. Backward walking effects on activation pattern of leg muscles in young females with patellofemoral pain syndrome.pdf
Sedhom, M. G., "BACKWARD WALKING TRAINING IMPROVES KNEE PROPRIOCEPTION IN NON ATHLETIC MALES", International Journal of Physiotherapy, vol. 4, issue 1, pp. 33-37, 2017. 06ijphy588.pdf
Mohamed, M., I. M. Moussa2, K. F. Mohamed, A. Samir, E. A. Nasr, M. H.Ashgan, S. AlRejaie, and M. E. Hatem, "BACTEC MGIT 960 TM system for screening of Mycobacterium Tuberculosis Complex Among Cattle", African Journal of Biotechnology, vol. 10, pp. 13919-13923, 2011. CU-PDF.pdf
Mohamed, M., I. M. Moussa, K. F. Mohamed, A. Samir, E. A. Nasr, M. H. Ashgan, S. AlRejaie, and M. E. Hatem, "BACTEC MGIT 960 TM system for screening of Mycobacterium tuberculosis complex among cattle", African Journal of Biotechnology, vol. 10, issue 63, no. 63: Academic Journals (Kenya), pp. 13919–13923, 2011. Abstract

n/a

Marwa, M., M. Moussa, I., F. Mohamed, Kh., A. Samir, and et al, "BACTEC MGIT 960 TM system for screening of Mycobacterium tuberculosis complex among cattle.", African Journal of Biotechnology., vol. 10, issue 63, pp. 13919 – 13923, 2011.
Hassan, R. M., D. M. Bassiouny, and Y. Matar, "Bacteremia Caused by Kocuria kristinae from Egypt: Are There More? A Case Report and Review of the Literature", Case Reports in Infectious Diseases, vol. 2016, pp. 1-4, 2016. 6318064.pdf
El-Mahallawy, H. A., S. S. Hassan, M. El-Wakil, and M. M. Moneer, "Bacteremia due to ESKAPE pathogens: An emerging problem in cancer patients", Journal of the Egyptian National Cancer Institute, vol. 28, issue 3, pp. 157 - 162, 2016. Abstract

BACKGROUND AND AIM: In recent years, a few of the antibiotic-resistant bacteria, known as ESKAPE pathogens, have been found responsible for serious infections. We investigated the risk factors, and impact of ESKAPE pathogens on course of blood stream infections (BSIs) in cancer patients in comparison to coagulase negative Staphylococci (CoNS).PATIENTS AND METHODS: The data of patients with ESKAPE positive blood cultures at National Cancer Institute, Cairo University were analyzed. Identification and antimicrobial susceptibility of isolates were done using Microscan Walk Away 96.
RESULTS: In a 6month period, ESKAPE pathogens were isolated from non-duplicate blood cultures in 81 episodes of 72 cases of pediatric cancer patients, while CoNS were isolated from 135 blood cultures of 116 patients. The ESKAPE pathogens isolated were Enterobacter spp., methicillin-resistant Staphylococcus aureus (MRSA), Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterococci in 12%, 23%, 37%, 10%, 9%, and 9% of episodes, respectively. Health-care acquired infections constituted 75% of ESKAPE infections. Duration of episodes and overall mortality were significantly higher in ESKAPE BSIs when compared to CoNS (14.5±7.6 versus 09.9±6.9), and (26% versus 4%); respectively, p value <0.001.
CONCLUSIONS: ESKAPE pathogens were significantly associated with higher rates of morbidity and mortality indicating the need for improving the means of prevention of these types of infections within health care premises. Microbiology laboratories have a role in defining more dangerous infections and rapid diagnostics are required in the era of resistance.

O.Elkhashab, M. Soliman, M. A. Zeid, and W. gad, "bacteremia in chronic hemodialysis patients", Medical Journal of Cairo University, vol. 51, pp. 201-208, 1983.
Khattab, R. A., N. A. Ahmed, Y. M. Ragab, and S. A. Rasmy, "Bacteria producing antimicrobials against Clostridium difficile isolated from human stool.", Anaerobe , vol. 63 (2020) 102206. DOI: 10.1016/j.anaerobe.2020.102206. PMID: 32339663., pp. 1-9, 2020.
H, A. - A., W. W, Scherner O, E. T, and K. MT., "Bacteria-Derived Compatible Solutes Ectoine and 5α-Hydroxyectoine Act as Intestinal Barrier Stabilizers to Ameliorate Experimental Inflammatory Bowel Disease.", J Nat Prod. 2015, vol. 78, issue 6, pp. 1309-15., 2015.
Abdel-Aziz, H., W. Wadie, O. Scherner, T. Efferth, and M. T. Khayyal, "Bacteria-Derived Compatible Solutes Ectoine and 5α-Hydroxyectoine Act as Intestinal Barrier Stabilizers to Ameliorate Experimental Inflammatory Bowel Disease.", Journal of natural products, vol. 78, issue 6, pp. 1309-15, 2015 Jun 26. Abstract

Earlier studies showed that the compatible solute ectoine (1) given prophylactically before induction of colitis by 2,4,6-trinitrobenzenesulfonic acid (TNBS) in rats prevented histological changes induced in the colon and the associated rise in inflammatory mediators. This study was therefore conducted to investigate whether ectoine (1) and its 5α-hydroxy derivative (2) would also be effective in treating an already established condition. Two days after inducing colitis in rats by instilling TNBS/alcohol in the colon, animals were treated orally once daily for 1 week with either 1 or 2 (50, 100, 300 mg/kg). Twenty-four hours after the last drug administration rats were sacrificed. Ulcerative lesions and colon mass indices were reduced by 1 and 2 in a bell-shaped manner. Best results were obtained with 100 mg/kg ectoine (1) and 50 mg/kg 5α-hydroxyectoine (2). The solutes normalized the rise in myeloperoxidase, TNFα, and IL-1β induced by TNBS but did not affect levels of reduced glutathione or ICAM-1, while reducing the level of fecal calprotectin, an established marker for inflammatory bowel disease. The findings indicate that the naturally occurring compatible solutes ectoine (1) and 5α-hydroxyectoine (2) possess an optimum concentration that affords maximal intestinal barrier stabilization and could therefore prove useful for better management of human inflammatory bowel disease.

Abdel-Aziz, H., W. Wadie, O. Scherner, T. Efferth, and M. T. Khayyal, "Bacteria-Derived Compatible Solutes Ectoine and 5α-Hydroxyectoine Act as Intestinal Barrier Stabilizers to Ameliorate Experimental Inflammatory Bowel Disease.", Journal of natural products, vol. 78, issue 6, pp. 1309-15, 2015 Jun 26. Abstract

Earlier studies showed that the compatible solute ectoine (1) given prophylactically before induction of colitis by 2,4,6-trinitrobenzenesulfonic acid (TNBS) in rats prevented histological changes induced in the colon and the associated rise in inflammatory mediators. This study was therefore conducted to investigate whether ectoine (1) and its 5α-hydroxy derivative (2) would also be effective in treating an already established condition. Two days after inducing colitis in rats by instilling TNBS/alcohol in the colon, animals were treated orally once daily for 1 week with either 1 or 2 (50, 100, 300 mg/kg). Twenty-four hours after the last drug administration rats were sacrificed. Ulcerative lesions and colon mass indices were reduced by 1 and 2 in a bell-shaped manner. Best results were obtained with 100 mg/kg ectoine (1) and 50 mg/kg 5α-hydroxyectoine (2). The solutes normalized the rise in myeloperoxidase, TNFα, and IL-1β induced by TNBS but did not affect levels of reduced glutathione or ICAM-1, while reducing the level of fecal calprotectin, an established marker for inflammatory bowel disease. The findings indicate that the naturally occurring compatible solutes ectoine (1) and 5α-hydroxyectoine (2) possess an optimum concentration that affords maximal intestinal barrier stabilization and could therefore prove useful for better management of human inflammatory bowel disease.

Abdel-Aziz, H., W. Wadie, O. Scherner, T. Efferth, and M. T. Khayyal, "Bacteria-Derived Compatible Solutes Ectoine and 5α-Hydroxyectoine Act as Intestinal Barrier Stabilizers to Ameliorate Experimental Inflammatory Bowel Disease.", Journal of natural products, vol. 78, issue 6, pp. 1309-15, 2015 Jun 26. Abstract

Earlier studies showed that the compatible solute ectoine (1) given prophylactically before induction of colitis by 2,4,6-trinitrobenzenesulfonic acid (TNBS) in rats prevented histological changes induced in the colon and the associated rise in inflammatory mediators. This study was therefore conducted to investigate whether ectoine (1) and its 5α-hydroxy derivative (2) would also be effective in treating an already established condition. Two days after inducing colitis in rats by instilling TNBS/alcohol in the colon, animals were treated orally once daily for 1 week with either 1 or 2 (50, 100, 300 mg/kg). Twenty-four hours after the last drug administration rats were sacrificed. Ulcerative lesions and colon mass indices were reduced by 1 and 2 in a bell-shaped manner. Best results were obtained with 100 mg/kg ectoine (1) and 50 mg/kg 5α-hydroxyectoine (2). The solutes normalized the rise in myeloperoxidase, TNFα, and IL-1β induced by TNBS but did not affect levels of reduced glutathione or ICAM-1, while reducing the level of fecal calprotectin, an established marker for inflammatory bowel disease. The findings indicate that the naturally occurring compatible solutes ectoine (1) and 5α-hydroxyectoine (2) possess an optimum concentration that affords maximal intestinal barrier stabilization and could therefore prove useful for better management of human inflammatory bowel disease.

Refai, M., "Bacterial and fungal diseases of buffaloes in Egypt.", J. Egypt. Vet. Med. Ass. , vol. 50, , pp. 427-447, 1990. bacterial_and_fungal_diseasis_in_buffaloes.pdf
Refai, M., "Bacterial and mycotic diseases of camels in Egypt. ", Proc. 1st int. Camel Conf., Dubai, United Arab Emerat, vol. 1, pp. 59-64 , 1992. bacterial_and_mycotic_diseases_of_camels.pdf
, A. M. M., "Bacterial Causes of Arthritis in Pigeons", International Journal of Zoology and Animal Biology, vol. 4, issue 1, 2021. bacterial-causes-of-arthritis-in-pigeons.pdf
Amer, M. M., and W. A. F. A. A. A. B. D. A. EL-GAHNY, "BACTERIAL CAUSES OF DECREASE IN PERFORMANCE OF BREEDER CHICKENS FLOCKS.", Beni-Suef Veterinary Medical Journal, , vol. 16, issue 1, pp. 61-69., 2006. bacterial_causes_of_decrease_in_performance.pdf
Yazeed, H. A. E., M. Elhariri, E. Saleh, M. A. Afifi, A. Samir, and M. Refai, "Bacterial Causes of Embryonic Death in Ostrich Egg", International Journal of Research Studies in Biosciences (IJRSB) , vol. 3, issue 8, pp. 46-52, 2015. engi_published_paper.pdf
Sayed, M. A., and K. F. Y. El-Yasergy, "Bacterial chitinase as a biocontrol agent of phytopathogenic fungi", Egypt. J. Biotechnol, vol. 50:, pp. 135-143. , 2015.